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Objective: To study whether lower arterial oxygen saturation (SaO2) and chronic obstructive pulmonary
disease (COPD) are associated with cerebral white matter lesions and lacunar infarcts.
Methods: We measured SaO2 twice with a pulse oximeter, assessed the presence of COPD, and
performed MRI in 1077 non-demented people from a general population (aged 60–90 years). We rated
periventricular white matter lesions (on a scale of 0–9) and approximated a total subcortical white matter
lesion volume (range 0–29.5 ml). All analyses were adjusted for age and sex and additionally for
hypertension, diabetes, body mass index, pack years smoked, cholesterol, haemoglobin, myocardial
infarction, and left ventricular hypertrophy.
Results: Lower SaO2 was independent of potential confounders associated with more severe
periventricular white matter lesions (score increased by 0.12 per 1% decrease in SaO2 (95% confidence
interval 0.01 to 0.23)). Participants with COPD had more severe periventricular white matter lesions than
those without (adjusted mean difference in score 0.70 (95% confidence interval 0.23 to 1.16)). Lower
SaO2 and COPD were not associated with subcortical white matter lesions or lacunar infarcts.
Conclusion: Lower SaO2 and COPD are associated with more severe periventricular white matter lesions.
C
erebral white matter lesions and lacunar brain infarcts
are frequently observed on magnetic resonance ima-
ging scans of elderly people.1–4 Evidence is accumulat-
ing that these lesions play an important role in the
development of cognitive decline and dementia.5–7 Although
the exact pathogenesis of these lesion is not fully understood,
they are considered to be caused by ischaemic small vessel
disease, with hypertension and increased age as the most
important risk factors. Degenerative changes of cerebral
small vessels result in narrowing and obstruction of the
arteriolar lumen and alteration of the cerebral autoregula-
tion, both resulting in hypoperfusion of the cerebral white
matter and basal ganglia.8
In addition to cerebral perfusion, the arterial oxygen
content determines the total amount of oxygen available in
the brain. Low arterial oxygen pressure strongly aggravates
brain damage caused by cerebral hypoperfusion. Pure
hypoxaemic insults, however, fail to cause brain damage.9
Whether lower arterial oxygen pressure in elderly people
plays a role in the pathophysiology of white matter lesions is
unknown.
The assessment of the arterial oxygen pressure is a
relatively invasive procedure and therefore not applicable in
a large population based study. The oxygen saturation of
haemoglobin, as assessed by pulse oximetry, is a non-invasive
measurement that gives an indication of the arterial oxygen
pressure. We studied the association between arterial oxygen
saturation (SaO2) and white matter lesions and lacunar
infarcts. Chronic obstructive pulmonary disease (COPD) is a
common disease among elderly people.10–13 Patients with
COPD experience oxygen deprivation for prolonged periods,
especially during physical exercise, exacerbation of disease,
and sleep.14 15 We therefore also examined the association
between COPD and white matter lesions and lacunar infarcts.
METHODS
Study sample
The Rotterdam Scan Study was designed to study the
aetiology and natural history of age related brain changes
in the elderly. Over the period 1995–96, we randomly selected
participants aged 60–90 years by sex and 5 year age strata
from the population based Zoetermeer16 and Rotterdam17
studies. These populations were almost entirely white. A
total of 1077 non-demented elderly persons participated in
our study (overall response 63%).3 Each person gave
informed consent to participate in our study, which had
been approved by the local medical ethics committee.
Arterial oxygen saturation and COPD
All participants underwent an interview and a physical
examination at the time of MRI scanning. SaO2 was
measured twice, 5 minutes apart, with a pulse oximeter
(Oxycount; Andos, Hamburg, Germany) on the right index
finger. The two measurements were averaged (correlation
coefficient was 0.73 and the range was 88–99%).
Participants were asked to bring all their prescription drugs
with them to the research centre. The research physicians
recorded these and checked their indication. COPD was
considered present if a person was taking inhalation
medication from at least one of the following groups:
sympaticomimetics, parasympaticolytics, or glucocortico-
steroids.
Measurements of other covariates
Blood pressure was measured twice on the right arm with a
random zero sphygmomanometer, and the average of these
two measurements was used. Hypertension was defined as a
systolic blood pressure of >140 mm Hg, a diastolic blood
pressure of >90 mm Hg, and/or the use of blood pressure
lowering medication.
We collected non-fasting blood samples from all partici-
pants. We considered diabetes mellitus to be present if a
person used oral anti-diabetics or insulin and/or had a
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glucose level >11.1 mmol/l. The body mass index was
calculated as weight (kg) divided by height squared (m2).
A research physician obtained information on smoking habits
using a structured questionnaire. Patients were categorised as
having smoked or never smoked. Furthermore, we calculated
for every participant the number of pack years smoked
(number of cigarettes per day6years of smoking/20). Serum
total cholesterol levels were measured from non-fasting
blood samples using an automated enzymatic method. The
presence of left ventricular hypertrophy and myocardial
infarction was assessed by MEANS interpretation of a 12
lead electrocardiogram (Acta electrocardiograph; Esaote,
Florence, Italy).18 Haemoglobin levels were assessed using a
standard and validated method.19
Cerebral white matter lesions and lacunar infarcts
All participants underwent MRI scanning of the brain. We
made axial T1, T2, and proton density weighted scans
on 1.5 T MRI scanners (MR Gyroscan; Philips, Best,
the Netherlands, and MR Vision; Siemens, Erlangen,
Germany). The slice thickness was 5 or 6 mm (scanner
dependent) with an inter-slice distance of 1 mm.
White matter lesions were considered present if visible as
hyperintense signals on proton density and T2 weighted
images, without prominent hypointensity on T1 weighted
scans. When the largest diameter of the white matter lesion
was directly adjacent to the ventricle, it was defined as
periventricular, otherwise as subcortical. The scoring method
has been described in detail previously.20 Briefly, periven-
tricular white matter lesions were rated semiquantitatively
from 0 (no lesion) to 3 (large confluent lesion) at three
regions (adjacent to the frontal horns, the lateral walls, and
the occipital horns of the lateral ventricle). We added the sum
of the region specific scores to acquire a total periventricular
white matter lesion score (range 0–9). We counted sub-
cortical white matter lesions in three size categories based
on their maximum diameter: small (,3 mm), medium
(3–10 mm), and large (.10 mm). A total volume was
approximated by assuming these subcortical lesions to be
spherical with a fixed maximum diameter (volume range
0–29.5 ml). Both inter- and intra-reader studies (n = 100)
showed good to excellent agreement (for periventricular
white matter lesion grade the kappa values were 0.79 and
0.90, respectively, and for subcortical white matter lesion
volume the intra-class correlation coefficients were 0.88 and
0.95, respectively). We defined lacunar infarcts as focal
hyperintensities on T2 weighted images 3–20 mm in size and
located in the subcortical white matter or basal ganglia.
Proton density scans were used to distinguish infarcts from
dilated perivascular spaces. Lesions in the white matter also
had to have corresponding prominent hypointensities on T1
weighted images for us to distinguish them from cerebral
white matter lesions.
Data analysis
The relation of SaO2 and periventricular and subcortical
white matter lesions was analysed using multiple linear
regression models with SaO2 categorised in tertiles and
subsequently with SaO2 as a continuous variable. We used
linear regression analysis to calculate adjusted mean differ-
ences of periventricular white matter lesion score and
subcortical white matter lesion volume between participants
with and without COPD. We analysed the association
between SaO2 and COPD and the presence of lacunar infarcts
by multiple logistic regression analysis; from these analyses
all people with cortical infarcts were excluded (n = 33). All
analyses were adjusted for age and sex and additionally for
hypertension, diabetes, body mass index, pack years smoked,
cholesterol level, haemoglobin concentration, myocardial
infarction, and left ventricular hypertrophy. We performed
supplementary analysis separately for those patients who had
ever smoked and those who had never smoked. All regression
analyses were followed by residual analysis to confirm
assumptions of the model.
RESULTS
Table 1 gives selected characteristics of the study population.
We measured SaO2 for all participants, except for 11 subjects
for whom we could not get a signal from the oximeter. These
11 people did not differ in the presented characteristics from
the participants that had complete data. Seventy three
participants had COPD; 31 (43%) had chronic bronchitis, 9
(12%) had lung emphysema, and 33 (45%) had a combina-
tion of both or was not further specified.
SaO2 was on average lower in men, those who were ever
cigarette smokers, and higher age. Participants with COPD
were on average older, more often men, and were more often
ever cigarette smokers. The unadjusted mean SaO2 was 0.84%
(95% confidence interval (CI) 0.55 to 1.13%) lower in
participants with COPD than in those without. Among the
smokers, those with COPD smoked on average more pack
years than those without COPD.
Fig 1 shows the association between SaO2 in tertiles
(means 95.3%, 96.7%, and 97.8%) and white matter lesions.
People in the lowest tertile of SaO2 had more severe
periventricular white matter lesions than those in the upper
tertile, but did not have more severe subcortical white matter
lesions. The age and sex adjusted mean periventricular white
matter lesion score increased by 0.12 per 1% decrease in SaO2
(95% CI 0.02 to 0.21). After additional adjustment for
hypertension, diabetes mellitus, body mass index, smoked
pack years, cholesterol level, haemoglobin concentration,
myocardial infarction, and left ventricular hypertrophy, this
association remained unaltered (periventricular white matter
lesions score increased by 0.12 per 1% decrease in SaO2 (95%
CI 0.01 to 0.23)). Arterial oxygen saturation was not
associated with volume of subcortical white matter lesions
(0.06 ml increase per 1% decrease in SaO2 (95% CI 20.07 to
0.20)) or the risk of lacunar infarcts (odds ratio 1.01 per 1%
decrease in SaO2 (95% CI 0.89 to 1.15)), adjusted for age and
sex. The association between SaO2 and periventricular white
matter lesion severity was not different for those who had
ever and those who had never smoked (increment of 0.12
(95% CI 20.02 to 0.25) v 0.11 (95% CI 20.08 to 0.30) per 1%
decrease in SaO2 in the fully adjusted model).
Table 1 Characteristics of the study population
in 1995–1996
All participants
(n = 1077)
Age, years 72.2 (7.4)
Women, % 51.5
Hypertension,% 73.0
Diabetes mellitus,% 7.0
Body mass index, kg/m2 26.7 (3.6)
Ever smoked cigarettes, % 66.4
Smoking, pack years 19.1 (24.0)
Total cholesterol, mmol/l 5.9 (1.0)
Haemoglobin, mmol/l 8.7 (0.7)
Left ventricular hypertrophy, % 2.9
Myocardial infarction, % 10.3
Oxygen saturation, % SaO2 96.5 (88-99)
Lacunar infarcts, %* 21.6
White matter lesion severity
Periventricular, score 0–9 2.4 (2.2)
Subcortical, ml 1.4 (2.9)
Values are percentages or unadjusted means (SD), or for
oxygen saturation the median (range).
*People with cortical infarcts were excluded (n = 33).
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Participants with COPD had more severe periventricular
white matter lesions than those without (table 2). This
difference was independent of vascular risk factors, and
observed in both ever and never cigarette smokers (age and
sex adjusted difference for those who had ever (0.59 (95% CI
0.08 to 1.11) and never (1.11 (95% CI 0.08 to 2.14) smoked).
Participants with and without COPD did not differ in
subcortical white matter lesion volume (table 2) or the risk
of lacunar infarcts (age and sex adjusted odds ratio 1.00 (95%
CI 0.54 to 1.87)).
DISCUSSION
In this population based study, we found that lower SaO2
was associated with more severe periventricular white matter
lesions, but not with subcortical white matter lesions or
lacunar infarcts. This association was independent of
vascular risk factors, haemoglobin concentration, and mea-
surements of cardiac function. Furthermore, we found that
participants with COPD had more severe periventricular
white matter lesions, but did not differ in subcortical white
matter lesion volume or in prevalence of lacunar infarcts.
The strengths of this study are the population based design
and the large number of elderly participants for whom MRI
scans were perfomed. Before interpreting the results, we
must address some methodological issues. The pulse oxi-
meter accurately and precisely measures SaO2 within the
range 70 to 100% compared with measures assessed by blood
gas analysis.21 22 All SaO2 measurements presented in this
paper were in this range. In 11 participants, the pulse
oximeter failed to give a signal, probably caused by cold
fingers or low peripheral perfusion. We do not think that the
exclusion of this small group, which did not differ from the
study population with respect to the measured covariates or
outcome variables (data not shown), has markedly influ-
enced our results.
SaO2 is an indirect measure of arterial oxygen pressure in
the cerebral arteries. The SaO2 is linked to the arterial oxygen
pressure by the oxygen–haemoglobin dissociation curve.
Changes in blood CO2 concentration, temperature, and 2,3-
diphosphoglycerate concentration shift the dissociation
curve.23 We did not measure these variables, but we
performed the oximetry for each patient under comparable
circumstances. Furthermore, pulse oximetry assesses SaO2 in
arterial blood, whereas these factors mainly affect the
relation between oxygen saturation and oxygen pressure in
capillary blood.23 We therefore think that SaO2 gives a good
indication of the arterial oxygen pressure.
Defining COPD as the use of medication for this indication
may have introduced misclassification. COPD cases that were
not being treated will have been missed, and this may explain
why the prevalence of COPD in our study is somewhat lower
than in some other population based studies.10 11 13 However,
the age and sex specific prevalence of COPD in our study was
comparable with a large Canadian study using health
questionnaires.12 Both SaO2 and the presence of COPD were
assessed without knowledge of other risk factors or presence
of white matter lesions. The MRI scans were rated by
researchers blinded to all other data. Therefore, any
misclassification in the assessment of SaO2 or COPD will be
random and result in an underestimation of the strength of
any association.
People with lower SaO2 had significantly more severe
periventricular white matter lesions. However, the differences
were not very large and probably do not represent clinically
significant disturbances on an individual level. It should be
noted that we studied a large cohort of non-demented elderly
people representative of the general population and not a
selected group of patients. Consequently, the majority of the
participants had SaO2 values within the normal range.
Within this population based range we found that a decrease
in SaO2 was associated with an increase in periventricular
white matter lesion severity. This observation was supported
by the consistent result with COPD.
In the Cardiovascular Health Study, an association
between lower forced expiratory volume in 1 second (a
measure of lung function) and white matter lesion severity
was observed.1 In that study, the association disappeared
after adjusting for sex and history of smoking. Smoking is the
most important determinant of COPD.11 13 However, we also
observed an association between COPD and white matter
lesions in subjects who had never smoked, indicating that
this relation was not based on the potential confounding
effect of smoking.
Chronic hypoperfusion is thought to play an important role
in the development of white matter lesions. Experimental
studies show that hypoxaemia in the absence of a reduced
cerebral blood flow does not result in neuronal damage.24–26
Hypoxaemia additional to hypoperfusion, however, strongly
exacerbates ischaemic brain damage.9 This difference in
effect between pure hypoxaemia and the combination of
hypoxaemia and ischaemia may be explained by the
physiological increase in cerebral blood flow under conditions
of reduced blood oxygen content.27 In our study, we did not
assess the cerebral blood flow of the cerebral white matter.
Figure 1 Association between tertiles of arterial oxygen saturation and
severity of periventricular (A) and subcortical (B) white matter lesions
(mean score or volume adjusted for age, sex, hypertension, diabetes
mellitus, body mass index, pack years smoked, cholesterol level,
haemoglobin concentration, prevalent myocardial infarction, and left
ventricular hypertrophy with 95% confidence intervals). *Significance:
p = 0.01 for difference between first and third tertile
Table 2 Mean differences (95% confidence interval) of
periventricular white matter lesion score and subcortical
white matter lesion volume (ml) between participants with
and without COPD
Model
Excess white matter lesions in participants with COPD
Periventricular score
(95% CI) p
Subcortical volume
(95% CI) p
1* 0.70 (0.23 to 1.16) ,0.01 0.43 (20.21 to 1.08) 0.19
2 0.69 (0.23 to 1.14) ,0.01 0.43 (20.22 to 1.08) 0.20
*Adjusted for age and sex.
Adjusted for age, sex, hypertension, diabetes mellitus, body mass index,
cholesterol level, pack years smoked.
CI, confidence interval.
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Therefore we can only speculate on the interaction between
ischaemia and hypoxaemia in the development of white
matter lesions.
The periventricular white matter is an arterial border zone
and therefore relatively hypoperfused, in particular when
total cerebral blood flow decreases and autoregulation is
impaired.28 Areas with severe white matter lesions show
hypoperfusion on perfusion weighted MRI and PET scan
studies.29–31 Furthermore, vasomotor reactivity is diminished
in people with severe white matter lesions.32 33 As a
consequence, the physiological compensation of hypoxaemia
might be insufficient in people with cerebral small vessel
disease, especially in border zone areas. Altered cerebral
autoregulation may be the main cause of periventricular
white matter lesions, whereas concentric narrowing of the
arteriolar lumen may be the main cause of subcortical white
matter lesions and lacunar infarcts. Lower SaO2 is possibly
more detrimental in combination with chronic or intermit-
tent hypoperfusion, as in disturbed autoregulation, than
in instances of acute hypoperfusion, as in arteriolar
obstruction.25
In conclusion, our study shows that COPD and lower SaO2
are associated with more severe periventricular white matter
lesions. This finding suggests that not only cerebral hypo-
perfusion, but also hypoxaemia may contribute to the
aetiology of periventricular white matter lesions.
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